SCHEMBL30716366

SCHEMBL30716366

CC(C)c1cnn2cnc(N3CCC(N)CC3)nc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DKK1 O94907 1/20 0.37
PTPN11 Q06124 1/20 0.36
KDM1A O60341 4/20 0.35
HRH3 Q9Y5N1 2/20 0.34
HRH4 Q9H3N8 1/20 0.34
ACVR1 Q04771 1/20 0.34
MAPK8 P45983 1/20 0.34
MAPK10 P53779 1/20 0.34
TLR9 Q9NR96 1/20 0.34
TLR8 Q9NR97 1/20 0.34
TLR7 Q9NYK1 1/20 0.34
CDK2 P24941 2/20 0.33
DYRK3 O43781 1/20 0.33
CCNT1 O60563 1/20 0.33
CCNA2 P20248 1/20 0.33
CLK1 P49759 1/20 0.33
CLK2 P49760 1/20 0.33
CLK3 P49761 1/20 0.33
CDK9 P50750 1/20 0.33
CDK5 Q00535 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26973963 0.77 CDK2 (0.37) DKK1KDM1AHRH3HRH4TLR9
SCHEMBL21486451 0.77 HRH3 (0.37) DKK1PTPN11HRH3HRH4CDK2
SCHEMBL21481495 0.72 CDK2 (0.36) CDK2DYRK3CCNT1CCNA2CLK1
SCHEMBL26134858 0.70 EGFR (0.42) PTPN11KDM1AMAPK8MAPK10CDK2
SCHEMBL25590744 0.70 KDM4E (0.33)
SCHEMBL23352055 0.69 CDK2 (0.33) CDK2DYRK3CCNT1CCNA2CLK1
SCHEMBL21481497 0.68 CDK2 (0.33) CDK2DYRK3CCNT1CCNA2CLK1
SCHEMBL15224900 0.68 KDM4E (0.42) CDK2DYRK3CCNT1CCNA2CLK1
SCHEMBL15224899 0.68 KDM4E (0.42) CDK2DYRK3CCNT1CCNA2CLK1
SCHEMBL29842036 0.68 CDK2 (0.52) TLR9TLR8TLR7CDK2CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023227125-A1 NEW FUSED-HETEROCYCLIC COMPOUND AS CDK INHIBITOR AND USE THEREOF 杭州德睿智药科技有限公司 2023-11-30 WO disclosed